Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| (2->1)-beta-D-fructofuranan {Inulin} - Actinomycetota |
📓
Inulin Supplementation Mitigates Gut Dysbiosis and Brain Impairment Induced by Mild Traumatic Brain Injury during Chronic Phase. Journal of cellular immunology (J Cell Immunol ) Vol: 4 Issue 2 Pages: 50-64 Pub: 2022 Epub: Authors Yanckello LM , Fanelli B , McCulloch S , Xing X , Sun M , Hammond TC , Colwell R , Gu Z , Ericsson AC , Chang YH , Bachstetter AD , Lin AL , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Actinomycetota |
📓
Dietary Supplementation with Inulin Modulates the Gut Microbiota and Improves Insulin Sensitivity in Prediabetes. International journal of endocrinology (Int J Endocrinol ) Vol: 2021 Issue Pages: 5579369 Pub: 2021 Epub: 2021 Jun 29 Authors Wang X , Wang T , Zhang Q , Xu L , Xiao X , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Actinomycetota |
📓
Effects of inulin on intestinal flora and metabolism-related indicators in obese polycystic ovary syndrome patients. European journal of medical research (Eur J Med Res ) Vol: 29 Issue 1 Pages: 443 Pub: 2024 Aug 31 Epub: 2024 Aug 31 Authors Li X , Jiang B , Gao T , Nian Y , Bai X , Zhong J , Qin L , Gao Z , Wang H , Ma X , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Actinomycetota |
📓
Dietary supplementation with inulin improves burn-induced skeletal muscle atrophy by regulating gut microbiota disorders. Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 2328 Pub: 2024 Jan 28 Epub: 2024 Jan 28 Authors Gao S , Zhao X , Leng Y , Xia Z , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Actinomycetota |
📓
Gut Health-Promoting Benefits of a Dietary Supplement of Vitamins with Inulin and Acacia Fibers in Rats. Nutrients (Nutrients ) Vol: 12 Issue 8 Pages: Pub: 2020 Jul 23 Epub: 2020 Jul 23 Authors Massot-Cladera M , Azagra-Boronat I , Franch À , Castell M , Rodríguez-Lagunas MJ , Pérez-Cano FJ , Publication Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
